Home/Filings/4/0001181431-10-056162
4//SEC Filing

FREY KIP 4

Accession 0001181431-10-056162

CIK 0001040416other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 12:04 PM ET

Size

17.2 KB

Accession

0001181431-10-056162

Insider Transaction Report

Form 4
Period: 2010-11-15
FREY KIP
Director
Transactions
  • Sale

    Common Stock

    2010-11-15$7.28/sh2,306$16,7881,000 total
  • Sale

    Common Stock

    2010-11-15$7.34/sh83$6100 total
  • Exercise/Conversion

    Common Stock

    2010-11-15$2.76/sh+7,934$21,8987,934 total
  • Sale

    Common Stock

    2010-11-15$7.26/sh198$1,4374,302 total
  • Sale

    Common Stock

    2010-11-15$7.27/sh996$7,2413,306 total
  • Sale

    Common Stock

    2010-11-15$7.33/sh517$3,790483 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2010-11-157,93432,066 total
    Exercise: $2.76Exp: 2012-06-04Common Stock (7,934 underlying)
  • Sale

    Common Stock

    2010-11-15$7.25/sh3,434$24,8974,500 total
  • Sale

    Common Stock

    2010-11-15$7.34/sh400$2,93683 total
Holdings
  • Common Stock

    (indirect: By Children)
    2,000
Footnotes (1)
  • [F1]Vested as to 30,000 shares in three equal annual installments commencing on the date of the Annual Meeting of Stockholders in 2003 for service as a director and as to 10,000 shares in three equal annual installments for service as a member of the Audit Committee.

Documents

1 file

Issuer

INSPIRE PHARMACEUTICALS INC

CIK 0001040416

Entity typeother

Related Parties

1
  • filerCIK 0001228447

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 12:04 PM ET
Size
17.2 KB